273 related articles for article (PubMed ID: 30192314)
1. Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.
Chen K; Zhang X; Ke X; Du G; Yang K; Zhai S
Ther Drug Monit; 2018 Dec; 40(6):663-674. PubMed ID: 30192314
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
[TBL] [Abstract][Full Text] [Related]
3. The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals.
Li G; Li Q; Zhang C; Yu Q; Li Q; Zhou X; Yang R; Yang X; Liu H; Yang Y
Front Genet; 2023; 14():1242711. PubMed ID: 37693307
[TBL] [Abstract][Full Text] [Related]
4. Medication therapy of high-dose methotrexate: An evidence-based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.
Song Z; Hu Y; Liu S; Wang G; Zhai S; Zhang X; Li Y; Du G; Shi Y; Chen Y; Dong M; Guo R; Guo W; Huang H; Huang X; Jing H; Ke X; Li G; Miao L; Niu X; Qiu F; Shen J; Tang J; Wang T; Wang X; Wang Z; Wu J; Zhan S; Zhang B; Zhang L; Zhang Y; Zhang W; Zhao L; Zhao L; Zhen J; Zheng H; Zhu Z; Jiang D; Huang Z; Tan Z; Lin Q; Zhao R
Br J Clin Pharmacol; 2022 May; 88(5):2456-2472. PubMed ID: 34729817
[TBL] [Abstract][Full Text] [Related]
5. Interpersonal Factors in the Pharmacokinetics and Pharmacodynamics of Voriconazole: Are CYP2C19 Genotypes Enough for Us to Make a Clinical Decision?
Zhong X; Tong X; Ju Y; Du X; Li Y
Curr Drug Metab; 2018; 19(14):1152-1158. PubMed ID: 29361899
[TBL] [Abstract][Full Text] [Related]
6. Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations.
Hicks JK; Gonzalez BE; Zembillas AS; Kusick K; Murthy S; Raja S; Gordon SM; Hanna R
Pharmacogenomics; 2016 May; 17(7):663-7. PubMed ID: 27143031
[TBL] [Abstract][Full Text] [Related]
7. CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
Zhu L; Brüggemann RJ; Uy J; Colbers A; Hruska MW; Chung E; Sims K; Vakkalagadda B; Xu X; van Schaik RH; Burger DM; Bertz RJ
J Clin Pharmacol; 2017 Feb; 57(2):235-246. PubMed ID: 27432796
[TBL] [Abstract][Full Text] [Related]
8. Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing.
Dolton MJ; Mikus G; Weiss J; Ray JE; McLachlan AJ
J Antimicrob Chemother; 2014 Jun; 69(6):1633-41. PubMed ID: 24554646
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy.
Kadam RS; Van Den Anker JN
Clin Pharmacokinet; 2016 Sep; 55(9):1031-43. PubMed ID: 26979736
[TBL] [Abstract][Full Text] [Related]
10. A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphisms.
Lemaitre F; Barbaz M; Scailteux LM; Uhel F; Tadié JM; Verdier MC; Bellissant E
Drug Metab Pharmacokinet; 2013; 28(5):439-41. PubMed ID: 23545593
[TBL] [Abstract][Full Text] [Related]
11. Effect of Therapeutic Drug Monitoring and Cytochrome P450 2C19 Genotyping on Clinical Outcomes of Voriconazole: A Systematic Review.
Lee J; Ng P; Hamandi B; Husain S; Lefebvre MJ; Battistella M
Ann Pharmacother; 2021 Apr; 55(4):509-529. PubMed ID: 32772568
[TBL] [Abstract][Full Text] [Related]
12. Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians.
Chawla PK; Nanday SR; Dherai AJ; Soman R; Lokhande RV; Naik PR; Ashavaid TF
Int J Clin Pharm; 2015 Oct; 37(5):925-30. PubMed ID: 26024717
[TBL] [Abstract][Full Text] [Related]
13. Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole.
Imamura CK; Furihata K; Okamoto S; Tanigawara Y
J Clin Pharmacol; 2016 Apr; 56(4):408-13. PubMed ID: 26239045
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles.
Chung H; Lee H; Han HK; An H; Lim KS; Lee YJ; Cho JY; Yoon SH; Jang IJ; Yu KS
Drug Des Devel Ther; 2015; 9():2609-16. PubMed ID: 25999694
[TBL] [Abstract][Full Text] [Related]
15. CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?
Owusu Obeng A; Egelund EF; Alsultan A; Peloquin CA; Johnson JA
Pharmacotherapy; 2014 Jul; 34(7):703-18. PubMed ID: 24510446
[TBL] [Abstract][Full Text] [Related]
16. Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.
Hassan A; Burhenne J; Riedel KD; Weiss J; Mikus G; Haefeli WE; Czock D
Ther Drug Monit; 2011 Feb; 33(1):86-93. PubMed ID: 21192313
[TBL] [Abstract][Full Text] [Related]
17. Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
Mikus G; Schöwel V; Drzewinska M; Rengelshausen J; Ding R; Riedel KD; Burhenne J; Weiss J; Thomsen T; Haefeli WE
Clin Pharmacol Ther; 2006 Aug; 80(2):126-35. PubMed ID: 16890574
[TBL] [Abstract][Full Text] [Related]
18. Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring.
Cojutti PG; Merelli M; Allegri L; Damante G; Bassetti M; Pea F
Br J Clin Pharmacol; 2019 Jan; 85(1):266-269. PubMed ID: 30414213
[TBL] [Abstract][Full Text] [Related]
19. High-Resolution Melting Assay for Genotyping Variants of the CYP2C19 Enzyme and Predicting Voriconazole Effectiveness.
Bernal-Martínez L; Alcazar Fuoli L; Miguel-Revilla B; Carvalho A; Cuétara Garcia MS; Garcia-Rodriguez J; Cunha C; Gómez-García de la Pedrosa E; Gomez-Lopez A
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910893
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics of Voriconazole in Chinese Patients with Hematopoietic Stem Cell Transplantation.
Chen C; Yang T; Li X; Ma L; Liu Y; Zhou Y; Ren H; Cui Y
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):659-668. PubMed ID: 31041728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
